{"id":"https://openalex.org/W2139285167","doi":"https://doi.org/10.1016/j.radonc.2015.03.028","title":"Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells","display_name":"Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells","alternate_titles":[],"publication_year":2015,"publication_date":"2015-05-14","ids":{"openalex":"https://openalex.org/W2139285167","doi":"https://doi.org/10.1016/j.radonc.2015.03.028","mag":"2139285167","pmid":"https://pubmed.ncbi.nlm.nih.gov/25981132"},"language":"en","primary_location":{"id":"doi:10.1016/j.radonc.2015.03.028","doi":"https://doi.org/10.1016/j.radonc.2015.03.028","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.radonc.2015.03.028","pdf_url":null,"source":{"id":"https://openalex.org/S144507673","display_name":"Radiotherapy and Oncology","issn_l":"0167-8140","issn":["0167-8140","1879-0887"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Radiotherapy and Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139285167"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053558319","display_name":"Caroline V.M. Verhagen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Caroline V.M. Verhagen","raw_affiliation_strings":["Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060740359","display_name":"Rosemarie de Haan","orcid":"https://orcid.org/0000-0002-3220-3190","observed_orcids":["https://orcid.org/0000-0002-3220-3190"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Rosemarie de Haan","raw_affiliation_strings":["Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands","Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands","Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022118770","display_name":"Floor Hageman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Floor Hageman","raw_affiliation_strings":["Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050721485","display_name":"Tim P.D. Oostendorp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Tim P.D. Oostendorp","raw_affiliation_strings":["Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049335064","display_name":"Annalisa L. E. Carli","orcid":"https://orcid.org/0000-0003-0312-1097","observed_orcids":["https://orcid.org/0000-0003-0312-1097"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Annalisa L.E. Carli","raw_affiliation_strings":["Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058717267","display_name":"Mark J. O\u2019Connor","orcid":"https://orcid.org/0000-0003-1823-625X","observed_orcids":["https://orcid.org/0000-0003-1823-625X"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark J. O\u2019Connor","raw_affiliation_strings":["AstraZeneca, DNA Damage Response Strategic Biology Area, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, DNA Damage Response Strategic Biology Area, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061340130","display_name":"Jos Jonkers","orcid":"https://orcid.org/0000-0002-9264-9792","observed_orcids":["https://orcid.org/0000-0002-9264-9792"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Jos Jonkers","raw_affiliation_strings":["Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044517920","display_name":"Marcel Verheij","orcid":"https://orcid.org/0000-0002-8079-7421","observed_orcids":["https://orcid.org/0000-0002-8079-7421"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marcel Verheij","raw_affiliation_strings":["Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands","Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands","Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012310620","display_name":"Michiel W. M. van den Brekel","orcid":"https://orcid.org/0000-0002-6338-6743","observed_orcids":["https://orcid.org/0000-0002-6338-6743","https://orcid.org/0000-0003-1212-6092"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Michiel W. van den Brekel","raw_affiliation_strings":["Department of Head and Neck Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Maxillofacial Surgery, Academic Medical Center, University of Amsterdam, Netherlands","Department of Head and Neck Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands","Department of Maxillofacial Surgery, Academic Medical Center, University of Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Head and Neck Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Maxillofacial Surgery, Academic Medical Center, University of Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I2898336195","https://openalex.org/I887064364"]},{"raw_affiliation_string":"Department of Head and Neck Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Maxillofacial Surgery, Academic Medical Center, University of Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076318367","display_name":"Conchita Vens","orcid":"https://orcid.org/0000-0002-8608-7236","observed_orcids":["https://orcid.org/0000-0002-8608-7236"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Conchita Vens","raw_affiliation_strings":["Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: c.vens@nki.nl","Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands","Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands"],"raw_orcid":"https://orcid.org/0000-0002-8608-7236","affiliations":[{"raw_affiliation_string":"Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: c.vens@nki.nl","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]},{"raw_affiliation_string":"Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5076318367"],"corresponding_institution_ids":["https://openalex.org/I2898336195"],"apc_list":{"value":3770,"currency":"USD","value_usd":3770},"apc_paid":null,"fwci":6.1985,"has_fulltext":false,"cited_by_count":122,"citation_normalized_percentile":{"value":0.98067204,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"116","issue":"3","first_page":"358","last_page":"365"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11176","display_name":"Radiation Therapy and Dosimetry","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/3108","display_name":"Radiation"},"field":{"id":"https://openalex.org/fields/31","display_name":"Physics and Astronomy"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11359","display_name":"Effects of Radiation Exposure","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olaparib","display_name":"olaparib","score":1.0},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8610000014305115},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":1.0},{"id":"https://openalex.org/keywords/homologous-recombination","display_name":"homologous recombination","score":0.8019999861717224},{"id":"https://openalex.org/keywords/brca2","display_name":"BRCA2","score":0.859000027179718},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9330000281333923},{"id":"https://openalex.org/keywords/radiation-dose","display_name":"radiation dose","score":0.49399998784065247},{"id":"https://openalex.org/keywords/drug-dose-dependence","display_name":"drug dose dependence","score":0.5839999914169312},{"id":"https://openalex.org/keywords/clonogenic-survival","display_name":"clonogenic survival","score":0.6919999718666077},{"id":"https://openalex.org/keywords/combined-radiotherapy","display_name":"combined radiotherapy","score":0.5550000071525574}],"concepts":[{"id":"https://openalex.org/C2779962180","wikidata":"https://www.wikidata.org/wiki/Q7083106","display_name":"Olaparib","level":5,"score":0.9938517808914185},{"id":"https://openalex.org/C2779138821","wikidata":"https://www.wikidata.org/wiki/Q7118227","display_name":"PARP inhibitor","level":5,"score":0.777658224105835},{"id":"https://openalex.org/C117262875","wikidata":"https://www.wikidata.org/wiki/Q5135057","display_name":"Clonogenic assay","level":3,"score":0.6640711426734924},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6286667585372925},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5717105269432068},{"id":"https://openalex.org/C102744134","wikidata":"https://www.wikidata.org/wiki/Q22280388","display_name":"Homologous recombination","level":3,"score":0.5219099521636963},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.4870612919330597},{"id":"https://openalex.org/C2776428644","wikidata":"https://www.wikidata.org/wiki/Q2126468","display_name":"Radiosensitizer","level":3,"score":0.4312340021133423},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40684887766838074},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37493976950645447},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2985295057296753},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.27683866024017334},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.24086683988571167},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17515376210212708},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10979324579238892},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000067856","descriptor_name":"Poly(ADP-ribose) Polymerase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010793","descriptor_name":"Phthalazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011829","descriptor_name":"Radiation Dosage","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011838","descriptor_name":"Radiation-Sensitizing Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059765","descriptor_name":"Homologous Recombination","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true}],"locations_count":11,"locations":[{"id":"doi:10.1016/j.radonc.2015.03.028","doi":"https://doi.org/10.1016/j.radonc.2015.03.028","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.radonc.2015.03.028","pdf_url":null,"source":{"id":"https://openalex.org/S144507673","display_name":"Radiotherapy and Oncology","issn_l":"0167-8140","issn":["0167-8140","1879-0887"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Radiotherapy and Oncology","raw_type":"journal-article"},{"id":"pmid:25981132","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25981132","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology","raw_type":"Journal Article"},{"id":"pmh:oai:dare.uva.nl:openaire_cris_publications/0ab46cc9-384e-480c-856d-575fd618588d","doi":null,"is_oa":false,"landing_page_url":"https://dare.uva.nl/personal/pure/en/publications/extent-of-radiosensitization-by-the-parp-inhibitor-olaparib-depends-on-its-dose-the-radiation-dose-and-the-integrity-of-the-homologous-recombination-pathway-of-tumor-cells(0ab46cc9-384e-480c-856d-575fd618588d).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306400088","display_name":"UvA-DARE (University of Amsterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I887064364","host_organization_name":"University of Amsterdam","host_organization_lineage":["https://openalex.org/I887064364"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Verhagen, C V M, de Haan, R, Hageman, F, Oostendorp, T P D, Carli, A L E, O'Connor, M J, Jonkers, J, Verheij, M, van den Brekel, M W & Vens, C 2015, 'Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells', Radiotherapy and oncology, vol. 116, no. 3, pp. 358-365. https://doi.org/10.1016/j.radonc.2015.03.028","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dare.uva.nl:publications/0ab46cc9-384e-480c-856d-575fd618588d","doi":null,"is_oa":false,"landing_page_url":"https://handle.uba.uva.nl/personal/pure/en/publications/extent-of-radiosensitization-by-the-parp-inhibitor-olaparib-depends-on-its-dose-the-radiation-dose-and-the-integrity-of-the-homologous-recombination-pathway-of-tumor-cells(0ab46cc9-384e-480c-856d-575fd618588d).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306400088","display_name":"UvA-DARE (University of Amsterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I887064364","host_organization_name":"University of Amsterdam","host_organization_lineage":["https://openalex.org/I887064364"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Verhagen, C V M, de Haan, R, Hageman, F, Oostendorp, T P D, Carli, A L E, O'Connor, M J, Jonkers, J, Verheij, M, van den Brekel, M W & Vens, C 2015, 'Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells', Radiotherapy and oncology, vol. 116, no. 3, pp. 358-365. https://doi.org/10.1016/j.radonc.2015.03.028","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/0aa1b680-b61e-4999-b59c-35b3ade3169f","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/0aa1b680-b61e-4999-b59c-35b3ade3169f","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Verhagen, C V M, de Haan, R, Hageman, F, Oostendorp, T P D, Carli, A L E, O'Connor, M J, Jonkers, J, Verheij, M, van den Brekel, M W & Vens, C 2015, 'Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells', Radiotherapy and oncology, vol. 116, no. 3, pp. 358-365. https://doi.org/10.1016/j.radonc.2015.03.028","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:research.vu.nl:openaire_cris_publications/9226cf47-500a-48f0-8378-034c3a22c8de","doi":null,"is_oa":false,"landing_page_url":"https://research.vu.nl/en/publications/9226cf47-500a-48f0-8378-034c3a22c8de","pdf_url":null,"source":{"id":"https://openalex.org/S4306401107","display_name":"VU Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Verhagen, C V M, de Haan, R, Hageman, F, Oostendorp, T P D, Carli, A L E, O'Connor, M J, Jonkers, J, Verheij, M, van den Brekel, M W & Vens, C 2015, 'Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells', Radiotherapy and Oncology, vol. 116, no. 3, pp. 358-365. https://doi.org/10.1016/j.radonc.2015.03.028","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/75774b3e-4571-4a65-8b57-3e82aa1a9394","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/extent-of-radiosensitization-by-the-parp-inhibitor-olaparib-depends-on-its-dose-the-radiation-dose-and-the-integrity-of-the-homologous-recombination-pathway-of-tumor-cells(75774b3e-4571-4a65-8b57-3e82aa1a9394).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Radiotherapy and oncology, 116(3), 358 - 365. Elsevier Ireland Ltd","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:repository.ubn.ru.nl:2066/152222","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2066/152222","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article / Letter to editor"},{"id":"pmh:ru:oai:repository.ubn.ru.nl:2066/152222","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2066/152222","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Radiotherapy and Oncology, 116, 358 - 65","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:uvapub:oai:dare.uva.nl:publications/0ab46cc9-384e-480c-856d-575fd618588d","doi":null,"is_oa":false,"landing_page_url":"https://dare.uva.nl/personal/pure/en/publications/extent-of-radiosensitization-by-the-parp-inhibitor-olaparib-depends-on-its-dose-the-radiation-dose-and-the-integrity-of-the-homologous-recombination-pathway-of-tumor-cells(0ab46cc9-384e-480c-856d-575fd618588d).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Radiotherapy and oncology, 116(3), 358 - 365. Elsevier","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:vu:oai:research.vu.nl:publications/9226cf47-500a-48f0-8378-034c3a22c8de","doi":null,"is_oa":false,"landing_page_url":"https://research.vu.nl/en/publications/9226cf47-500a-48f0-8378-034c3a22c8de","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Radiotherapy and Oncology, 116(3), 358 - 365. Elsevier Ireland Ltd","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W1575172090","https://openalex.org/W1724512254","https://openalex.org/W1969330686","https://openalex.org/W1973268287","https://openalex.org/W1975981807","https://openalex.org/W1994432408","https://openalex.org/W1996140916","https://openalex.org/W2000425014","https://openalex.org/W2003601710","https://openalex.org/W2004789696","https://openalex.org/W2008355675","https://openalex.org/W2009007206","https://openalex.org/W2014599726","https://openalex.org/W2026576427","https://openalex.org/W2042251066","https://openalex.org/W2042844721","https://openalex.org/W2061762018","https://openalex.org/W2065167958","https://openalex.org/W2070656260","https://openalex.org/W2074018533","https://openalex.org/W2085994266","https://openalex.org/W2091814658","https://openalex.org/W2094847705","https://openalex.org/W2096843793","https://openalex.org/W2097583984","https://openalex.org/W2101519297","https://openalex.org/W2110017381","https://openalex.org/W2111437716","https://openalex.org/W2117692326","https://openalex.org/W2139596299","https://openalex.org/W2145409983","https://openalex.org/W2160113753","https://openalex.org/W2168169655","https://openalex.org/W2168715841","https://openalex.org/W2171208628","https://openalex.org/W2171972386","https://openalex.org/W3093265161"],"related_works":["https://openalex.org/W2581329010","https://openalex.org/W2997087259","https://openalex.org/W2131874020","https://openalex.org/W2592293880","https://openalex.org/W2740155286","https://openalex.org/W2113996395","https://openalex.org/W2883804409","https://openalex.org/W2792971967","https://openalex.org/W2073744682","https://openalex.org/W2972454942"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139285167","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":17},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
